Clinical Trial Update: Safety, Pharmacokinetics and Potential Activity of HE3286 in Obese Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety, pharmacokinetics and potential activity of HE-3286 in obese adults with insulin resistance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Drugs mentioned

• HE-3286 (HE3286)

Snippet

Sponsor: Harbor Therapeutics | Conditions: Insulin Resistance | Phase 1 | Status: COMPLETED